Abstract
Purpose of Review
Review MRI neuroimaging techniques which utilize tissue susceptibility.
Recent Findings
The evaluation of neuropathologies using MRI methods that leverage tissue susceptibility have become standard practice, especially to detect blood products or mineralization. Additionally, emerging MRI techniques have the ability to provide new information based on tissue susceptibility properties in a robust and quantitative manner.
Summary
This paper discusses these advanced susceptibility imaging techniques and their clinical applications.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Wang Y. Principles of magnetic resonance imaging: physics concepts, pulse sequences, and biomedical applications. CreateSpace Independent Publishing Platform; 2012.
Vernooij MW, et al. Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. Radiology. 2008;248(1):272–7.
Shmueli K, et al. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med. 2009;62(6):1510–22.
Reichenbach JR, et al. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology. 1997;204(1):272–7.
Haacke EM, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol. 2009;30(1):19–30.
Tong KA, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology. 2003;227(2):332–9.
Tong KA, et al. Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol. 2004;56(1):36–50.
Cheng AL, et al. Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke. 2013;44(10):2782–6.
Soman S, et al. Improved T2* imaging without increase in scan time: SWI processing of 2D gradient echo. AJNR Am J Neuroradiol. 2013;34(11):2092–7.
de Rochefort L, et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med. 2010;63(1):194–206.
Wang Y, et al. Magnetic source MRI: a new quantitative imaging of magnetic biomarkers. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:53–6.
Kressler B, et al. Nonlinear regularization for per voxel estimation of magnetic susceptibility distributions from MRI field maps. IEEE Trans Med Imaging. 2010;29(2):273–81.
•• Wang Y, Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med. 2015;73(1):82–101. Covers core features of susceptibilty imaging.
Haacke EM, et al. Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging. 2015;33(1):1–25.
Liu C, et al. Quantitative susceptibility mapping: contrast mechanisms and clinical applications. Tomography. 2015;1(1):3–17.
Reichenbach JR, et al. Quantitative susceptibility mapping: concepts and applications. Clin Neuroradiol. 2015;25(Suppl 2):225–30.
Rigolo L, et al. Development of a clinical functional magnetic resonance imaging service. Neurosurg Clin N Am. 2011;22(2):307–14.
Ogawa S, et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A. 1990;87(24):9868–72.
Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging. 2005;22(6):710–7.
Iv M, et al. Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. Nanomedicine (Lond). 2015;10(6):993–1018.
Faul M et al. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002–2006, N.C.f.I.P.a.C. Centers for Disease Control and Prevention, Editor. 2010, Centers for Disease Control and Prevention. National Center for Injury Prevention and Control: Atlanta (GA).
Mittal S, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol. 2009;30(2):232–52.
Toth A, et al. Microbleeds may expand acutely after traumatic brain injury. Neurosci Lett. 2016;617:207–12.
Choi JI, et al. Comparison of subgroups based on hemorrhagic lesions between SWI and FLAIR in pediatric traumatic brain injury. Childs Nerv Syst. 2014;30(6):1011–9.
Geurts BH, et al. The reliability of magnetic resonance imaging in traumatic brain injury lesion detection. Brain Inj. 2012;26(12):1439–50.
Park JH, et al. Detection of traumatic cerebral microbleeds by susceptibility-weighted image of MRI. J Korean Neurosurg Soc. 2009;46(4):365–9.
Sharp DJ, Ham TE. Investigating white matter injury after mild traumatic brain injury. Curr Opin Neurol. 2011;24(6):558–63.
Iwamura A, et al. Diffuse vascular injury: convergent-type hemorrhage in the supratentorial white matter on susceptibility-weighted image in cases of severe traumatic brain damage. Neuroradiology. 2012;54(4):335–43.
Iwasaki H, Fujita Y, Hara M. Susceptibility-weighted imaging in acute-stage pediatric convulsive disorders. Pediatr Int. 2015;57(5):922–9.
Verma RK, et al. Focal and generalized patterns of cerebral cortical veins due to non-convulsive status epilepticus or prolonged seizure episode after convulsive status epilepticus—a mri study using susceptibility weighted imaging. PLoS ONE. 2016;11(8):e0160495.
Calabresi, P.A., Multiple sclerosis and demyelinating conditions of the central nervous system. 25th ed. Goldman-Cecil Medicine. Vol. 2. Amsterdam: Elsevier; 2016.
Chen W, et al. Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology. 2014;271(1):183–92.
Oztoprak B, Oztoprak I, Yildiz OK. The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study. Clin Radiol. 2016;71(5):418–26.
Hodel J, et al. Brain magnetic susceptibility changes in patients with natalizumab-associated progressive multifocal leukoencephalopathy. AJNR Am J Neuroradiol. 2015;36(12):2296–302.
Khamaysi Z, et al. Clinical and imaging findings in patients with neurosyphilis: a study of a cohort and review of the literature. Int J Dermatol. 2014;53(7):812–9.
Pesaresi I, et al. Susceptibility-weighted imaging in parenchymal neurosyphilis: identification of a new MRI finding. Sex Transm Infect. 2015;91(7):489–92.
Toh CH, et al. Differentiation of pyogenic brain abscesses from necrotic glioblastomas with use of susceptibility-weighted imaging. AJNR Am J Neuroradiol. 2012;33(8):1534–8.
Antulov R, et al. Differentiation of pyogenic and fungal brain abscesses with susceptibility-weighted MR sequences. Neuroradiology. 2014;56(11):937–45.
Bijlsma MW, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006–14: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339–47.
Bosemani T, Poretti A, Huisman TA. Susceptibility-weighted imaging in pediatric neuroimaging. J Magn Reson Imaging. 2014;40(3):530–44.
Santhosh K, et al. Susceptibility weighted imaging: a new tool in magnetic resonance imaging of stroke. Clin Radiol. 2009;64(1):74–83.
Polan RM, et al. Susceptibility-weighted imaging in pediatric arterial ischemic stroke: a valuable alternative for the noninvasive evaluation of altered cerebral hemodynamics. AJNR Am J Neuroradiol. 2015;36(4):783–8.
Elnekeidy AE, Yehia A, Elfatatry A. Importance of susceptibility weighted imaging (SWI) in management of cerebro-vascular strokes (CVS). Alexandria J Med. 2014;50(1):83–91.
Moulin T, et al. Hemorrhagic infarcts. Eur Neurol. 1994;34(2):64–77.
Copen WA, Schaefer PW, Wu O. MR perfusion imaging in acute ischemic stroke. Neuroimaging Clin N Am. 2011;21(2):259–83.
Kao HW, Tsai FY, Hasso AN. Predicting stroke evolution: comparison of susceptibility-weighted MR imaging with MR perfusion. Eur Radiol. 2012;22(7):1397–403.
Miyasaka T, et al. Application of susceptibility weighted imaging (SWI) for evaluation of draining veins of arteriovenous malformation: utility of magnitude images. Neuroradiology. 2012;54(11):1221–7.
Tsui YK, et al. Susceptibility-weighted imaging for differential diagnosis of cerebral vascular pathology: a pictorial review. J Neurol Sci. 2009;287(1–2):7–16.
George U, et al. Susceptibility-weighted imaging in the evaluation of brain arteriovenous malformations. Neurol India. 2010;58(4):608–14.
Lee BC, et al. MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol. 1999;20(7):1239–42.
Bulut HT, Sarica MA, Baykan AH. The value of susceptibility weighted magnetic resonance imaging in evaluation of patients with familial cerebral cavernous angioma. Int J Clin Exp Med. 2014;7(12):5296–302.
Chaudhry US, De Bruin DE, Policeni BA. Susceptibility-weighted MR imaging: a better technique in the detection of capillary telangiectasia compared with T2* gradient-echo. AJNR Am J Neuroradiol. 2014;35(12):2302–5.
Tamer H, et al. Hemodynamic analysis of an adult vein of Galen aneurysm malformation by use of 3D image-based computational fluid dynamics. AJNR Am J Neuroradiol. 2003;24(6):1075–82.
Tong KA, et al. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol. 2008;29(1):9–17.
Verschuuren S, et al. Susceptibility-weighted imaging of the pediatric brain. AJR Am J Roentgenol. 2012;198(5):W440–9.
Dai Y, et al. Visualizing cerebral veins in fetal brain using susceptibility-weighted MRI. Clin Radiol. 2014;69(10):e392–7.
Kelly JE, et al. Susceptibility-weighted imaging helps to discriminate pediatric multiple sclerosis from acute disseminated encephalomyelitis. Pediatr Neurol. 2015;52(1):36–41.
Hu J, et al. MR susceptibility weighted imaging (SWI) complements conventional contrast enhanced T1 weighted MRI in characterizing brain abnormalities of Sturge–Weber syndrome. J Magn Reson Imaging. 2008;28(2):300–7.
Hingwala D, et al. Clinical utility of susceptibility-weighted imaging in vascular diseases of the brain. Neurol India. 2010;58(4):602–7.
Franceschi AM, et al. Use of susceptibility-weighted imaging (SWI) in the detection of brain hemorrhagic metastases from breast cancer and melanoma. J Comput Assist Tomogr. 2016;40(5):803–5.
Hsu CC, et al. Susceptibility-weighted imaging of glioma: update on current imaging status and future directions. J Neuroimaging. 2016;26(4):383–90.
Daldrup-Link HE, et al. MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles. Clin Cancer Res. 2011;17(17):5695–704.
Mohammed W, et al. Clinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a review. Cancer Imaging. 2013;13:186–95.
Cha S, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223(1):11–29.
Wang X, et al. Neuronavigation-assisted trajectory planning for deep brain biopsy with susceptibility-weighted imaging. Acta Neurochir (Wien). 2016;158(7):1355–62.
Hertel F, et al. Susceptibility-weighted MRI for deep brain stimulation: potentials in trajectory planning. Stereotact Funct Neurosurg. 2015;93(5):303–8.
Liu T, et al. Improved subthalamic nucleus depiction with quantitative susceptibility mapping. Radiology. 2013;269(1):216–23.
Wang M, et al. Susceptibility weighted imaging in detecting hemorrhage in acute cervical spinal cord injury. Magn Reson Imaging. 2011;29(3):365–73.
Martin N, et al. Comparison of MERGE and axial T2-weighted fast spin-echo sequences for detection of multiple sclerosis lesions in the cervical spinal cord. AJR Am J Roentgenol. 2012;199(1):157–62.
Ishizaka K, et al. Detection of normal spinal veins by using susceptibility-weighted imaging. J Magn Reson Imaging. 2010;31(1):32–8.
Katayama Y, et al. Continuous monitoring of jugular bulb oxygen saturation as a measure of the shunt flow of cerebral arteriovenous malformations. J Neurosurg. 1994;80(5):826–33.
Cai M, et al. Susceptibility-weighted imaging of the venous networks around the brain stem. Neuroradiology. 2015;57(2):163–9.
Liu T, et al. Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging. Magn Reson Med. 2011;66(3):777–83.
Liu J, et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage. 2012;59(3):2560–8.
Schweser F, et al. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage. 2012;62(3):2083–100.
Wu B, et al. Whole brain susceptibility mapping using compressed sensing. Magn Reson Med. 2012;67(1):137–47.
Liu T, et al. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn Reson Med. 2009;61(1):196–204.
Wharton S, Bowtell R. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. Neuroimage. 2010;53(2):515–25.
Deistung A, et al. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage. 2013;65:299–314.
Khabipova D, et al. A modulated closed form solution for quantitative susceptibility mapping–a thorough evaluation and comparison to iterative methods based on edge prior knowledge. Neuroimage. 2015;107:163–74.
Sodickson DK, Manning WJ. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med. 1997;38(4):591–603.
Pruessmann KP, et al. SENSE: sensitivity encoding for fast MRI. Magn Reson Med. 1999;42(5):952–62.
Griswold MA, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47(6):1202–10.
Breuer FA, et al. Controlled aliasing in volumetric parallel imaging (2D CAIPIRINHA). Magn Reson Med. 2006;55(3):549–56.
Bilgic B, et al. Wave-CAIPI for highly accelerated 3D imaging. Magn Reson Med. 2015;73(6):2152–62.
Moriguchi H, Duerk JL. Bunched phase encoding (BPE): a new fast data acquisition method in MRI. Magn Reson Med. 2006;55(3):633–48.
Zahneisen B, et al. Three-dimensional Fourier encoding of simultaneously excited slices: generalized acquisition and reconstruction framework. Magn Reson Med. 2014;71(6):2071–81.
Langkammer C, et al. Fast quantitative susceptibility mapping using 3D EPI and total generalized variation. Neuroimage. 2015;111:622–30.
Wu B, et al. Fast and tissue-optimized mapping of magnetic susceptibility and T2* with multi-echo and multi-shot spirals. Neuroimage. 2012;59(1):297–305.
Bilgic B, et al. Rapid multi-orientation quantitative susceptibility mapping. Neuroimage. 2016;125:1131–41.
de Rochefort L, et al. In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI. Med Phys. 2008;35(12):5328–39.
Liu Z, et al. Preconditioned total field inversion (TFI) method for quantitative susceptibility mapping. Magn Reson Med. 2016;62:1510–22.
Kudo K, et al. Oxygen extraction fraction measurement using quantitative susceptibility mapping: comparison with positron emission tomography. J Cereb Blood Flow Metab. 2016;36(8):1424–33.
• Fan AP, et al. Quantitative oxygenation venography from MRI phase. Magn Reson Med. 2014;72(1):149–59. Describes details of MR venography using susceptibility imaging.
Jain V, Langham MC, Wehrli FW. MRI estimation of global brain oxygen consumption rate. J Cereb Blood Flow Metab. 2010;30(9):1598–607.
Haacke EM, et al. In vivo measurement of blood oxygen saturation using magnetic resonance imaging: a direct validation of the blood oxygen level-dependent concept in functional brain imaging. Hum Brain Mapp. 1997;5(5):341–6.
Fan AP, et al. Baseline oxygenation in the brain: correlation between respiratory-calibration and susceptibility methods. Neuroimage. 2016;125:920–31.
Xu B, et al. Quantification of cerebral perfusion using dynamic quantitative susceptibility mapping. Magn Reson Med. 2015;73(4):1540–8.
Cetin, S., et al. Vessel orientation constrained quantitative susceptibility mapping (QSM) reconstruction. In Ourselin S et al., editors. Medical image computing and computer-assisted intervention – MICCAI 2016: 19th International Conference, Athens, Greece, October 17–21, 2016, Proceedings, Part III, . 2016, Springer International Publishing: Cham. p. 467–474.
Bazin, P.L., et al. Vessel segmentation from quantitative susceptibility maps for local oxygenation venography. In: 2016 IEEE 13th International Symposium on Biomedical Imaging (ISBI) 2016.
Dula AN, et al. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T. Mult Scler. 2016;22(3):320–8.
• Barry RL, et al. Resting state functional connectivity in the human spinal cord. Elife. 2014;3:e02812. Describes core principles of spinal cord functional connectivity.
Delso G, et al. Anatomic evaluation of 3-dimensional ultrashort-echo-time bone maps for PET/MR attenuation correction. J Nucl Med. 2014;55(5):780–5.
Sheth V, et al. Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: phantom, specimen, volunteer and multiple sclerosis patient studies. Neuroimage. 2016;136:37–44.
Du J, et al. Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner. Neuroimage. 2014;87:32–41.
Li W, et al. Susceptibility tensor imaging (STI) of the brain. NMR Biomed. 2016;66(3):777–83.
Haacke EM, Reichenbach R Jr. Susceptibility weighted imaging in MRI: basic concepts and clinical applications. Hoboken: Wiley-Blackwell; 2011.
Acknowledgements
Audrey Fan reports a grant from Stanford Neurosciences Institute and research support from GE Healthcare. Yi Wang reports grants (R01NS07230, 090464, 095562). Berkin Bilgic acknowledges support from grants NIBIB R01 EB02061302, R01 EB01733703 and NIMH R24 MH10609603. Robert Barry acknowledges support from grant NIBIB R00 EB016689. Jiang Du acknowledges support from grant 1R01 NS092650.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Salil Soman, Jose A. Bregni, Berkin Bilgic, Ursula Nemec, Zhe Liu, Robert L. Barry, Jiang Du, Keith Main, Jerome Yesavage, Maheen M Adamson, and Michael Moseley each declare no potential conflicts of interest. Yi Wang is an inventor on QSM patent issued.
Human and Animal Rights and Informed Consent
All the images in this paper were obtained from human subjects under IRB approved protocols.
Additional information
This article is part of the Topical Collection on Neuroimaging.
Rights and permissions
About this article
Cite this article
Soman, S., Bregni, J.A., Bilgic, B. et al. Susceptibility-Based Neuroimaging: Standard Methods, Clinical Applications, and Future Directions. Curr Radiol Rep 5, 11 (2017). https://doi.org/10.1007/s40134-017-0204-1
Published:
DOI: https://doi.org/10.1007/s40134-017-0204-1